LABT logo

LABT Lakewood-Amedex Biotherapeutics, Inc.

NASDAQ Global Market · Biotechnology · Healthcare

$0.24
+0.02 (+9.30%)

Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States. The company offers products from its Bisphosphocin class, a novel class of antimicrobial agents a broad range of infections, including those affecting the skin, bladder, and lungs. It also develops Nu-3, a topical antimicrobial for infected diabetic fo…

Market Cap: $419.8Kwww.lakewoodamedex.com

Price

No data yet.

Social Signal Score

45
5d
—
30d
30
1 mentions
—
60d
52
6 mentions
—
90d
54
8 mentions
—
news: 8

Revenue

$0.00
$0.00
Mar 2024Jun 2026

Analyst Estimates

FY2026
$4.96
$4.96–$4.96
1 analysts
FY2027
$0.16-97% YoY
$-1.01–$1.32
2 analysts
FY2028
$-1.23-866% YoY
$-1.29–$-1.16
2 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Kelvin Cooper
Sector
Healthcare
Industry
Biotechnology
Employees
5
Beta
-4.76
Country
US
www.lakewoodamedex.com